VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis

Xavier Argemi, Yves Hansmann, P. Riegel et al.|Clinical Microbiology and Infection|2016

Cited by 37